MedPath

A pilot cohort study of autologous bone marrow derived stem cells and platelet rich plasma therapy after hysteroscopy

Not Applicable
Recruiting
Conditions
Diseases of The genitoruinary system
Registration Number
KCT0004208
Lead Sponsor
Bundang CHA General Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
35
Inclusion Criteria

1. Infertility patients diagnosed with severe Ashman's syndrome through hysteroscopic screening despite the treatment of at least 2 cycles of hormone therapy, the patient was found to have a history of rare menstruation or a maximum thickness of less than 6 mm
2. Body mass index <30kg / m2
3. Who wants to get pregnant
4. Those without abnormal findings in preoperative examination
5. The patient decided to participate in the study and both the subject and the spouse signed the agreement

Exclusion Criteria

1.Hemoglobin < 10.0, Platelet<130,000 or other hematologic diseases
2.Currently suffering from pelvic inflammatory disease
3.Uterine or pelvic conditions required additional treatment for pregnancy (uterine anomaly, submucosal myoma, adenomyosis with an antero-posterior diameter of 7 cm or more, Severe endometriosis stage 3-4)
4.Uncontrolled endocrine or medical illness.
5. A person who has been judged to be inappropriate medically by the clinical trial researcher

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
second look hysteroscopy
Secondary Outcome Measures
NameTimeMethod
Changes in amount of menstrual blood;uterine sonography;pregnancy
© Copyright 2025. All Rights Reserved by MedPath